Medpage Today on MSN21h
Long-Acting Injection Better for PrEP in Men, Gender-Diverse Groups
There was also a 96% reduction in risk compared with background HIV incidence of 2.37 per 100 person-years among individuals ...
Too Old to Operate21h
Q&A: Addressing Barriers to Long-Acting Injectable PrEP for Transgender Women
Research shows many transgender women in the U.S. express interest in long-acting injectable PrEP but face barriers to ...
Medscape7d
Long-Acting Risperidone Injection
Long-acting risperidone is a suspension administered by intramuscular injection in the upper-outer gluteal area. It consists of risperidone impregnated in microspheres composed of a biodegradable ...
Medscape1mon
Long-Acting Risperidone Injection
Long-acting risperidone injection was released for marketing for the treatment of schizophrenia in the United States in October 2003. The drug was available in 45 countries as of December 2003.
pharmaphorum8y
Could six-times-a-year injection become standard HIV treatment?
ViiV Healthcare and Janssen say injections of two new long-acting ... The regimen of two investigational long acting, intramuscular (IM) formulations of Janssen's rilpivirine and ViiV ...
Nature8y
Refractory neuroendocrine tumor—response to liposomal doxorubicin and capecitabine
An intramuscular injection of 20 mg long-acting octreotide was administered every 4 weeks. After 2 months of treatment, a total-body CT scan was performed to assess the tumor response to this ...
Morningstar20d
ViiV Healthcare expands on real-world data supporting use of long-acting therapies in diverse patient populations at HIV Glasgow
New analyses highlight use of long-acting injectable Vocabria + Rekambys (cabotegravir + rilpivirine LA) in clinical trial and real-world populations, and the economic and public health impact of ...